Cerus Corporation operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cerus with three other
companies in this sector in the United States:
Infusystems Holdings Inc.
sales of $67.14 million
of which 100%
was Surgical and Medical Instruments), and
Antares Pharma, Inc.
of which 48%
was Partnered product sales).
During the year ended December of 2018, sales at
Cerus were $76.05 million.
increase of 48.2%
versus 2017, when the company's sales were $51.33 million.
This was the third consecutive year of growth at Cerus.